On July 18, 2025, the U.S. Court of Appeals for the Federal Circuit reversed a $106 million jury verdict in Colibri Heart Valve LLC v. Medtronic CoreValve, LLC, No. 2023-2153, finding that Colibri’s infringement claim under...more
8/5/2025
/ Appeals ,
CAFC ,
Claim Amendments ,
Doctrine of Equivalents ,
Life Sciences ,
Medical Devices ,
Medtronic ,
Patent Infringement ,
Patent Litigation ,
Patent Prosecution ,
Patents ,
Pharmaceutical Patents ,
Prosecution History Estoppel